期刊
XENOTRANSPLANTATION
卷 30, 期 3, 页码 -出版社
WILEY
DOI: 10.1111/xen.12805
关键词
clinical trials; Federal Drug Administration; genetic modifications; heart xenotransplantation; immunosuppression; kidney xenotransplantation; pig-to-human; public perception
After a pause caused by the COVID-19 pandemic, xenotransplantation literature updates are now restarting. Recent clinical cases and increased interest in the field have prompted the decision to reinstate this section. Pig-to-human xenotransplantation presents unique challenges that will be given specific attention. This issue aims to cover the gap and include the most relevant publications from March 2021 to March 2023.
After a significant hiatus imposed by the COVID-19 pandemic, we hereby restart Xenotransplantation literature updates. With the recently performed clinical xenotransplantation cases and the much-heightened interest in the field, we have determined that this is an optimal time to reinstate this section. There has been an invigorated focus on unique challenges posed by pig-to-human xenotransplantation, and specific attention will be given to this aspect. In this issue, we aimed to cover the gap and compiled the most relevant publications from March 2021 to March 2023.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据